retatrutide ly3437943 parkinson's disease clinical trial Everyone's talking about GLP1s for weight loss but the research on stopped me in my tracks. It showed a 17x reduction in tumor volume for lung cancer models and a 14x 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

Many patients report: Nausea Mild stomach discomfort Constipation or diarrhea Occasional fatigue These effects are usually most noticeable when you first start the medication or when your dose increases

Youre suppressing appetite, improving how the body handles food, and increasing energy expenditure all from one molecule

Those with severe gastrointestinal conditions, including gastroparesis: Given the drug's effects on gastric motility, individuals with gastroparesis or other severe upper gastrointestinal disorders may experience worsening symptoms

Both the Use of GLP-1 agonists has increased greatly since they were first approved

Triple-agonist peptides represent one of the most ambitious approaches to exploring these interactions